Clinical Trial Update: Study of Docosahexanoic Acid in Patients With Cystic Fibrosis (CF) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating docosahexanoic acid in patients with cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Docosahexanoic acid (docosahexanoic acid)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED